Erratum: Vol. 71, No. 10

Details

• Journal Article:
  Morbidity and Mortality Weekly Report (MMWR)
• Description:
  Erratum for: AbbottA , MontgomerySP , ChanceyRJ . Characteristics and adverse events of patients for whom nifurtimox was released through CDC-sponsored investigational new drug program for treatment of Chagas disease—United States, 2001–2021. MMWR Morb Mortal Wkly Rep 2022;71:371–4. 10.15585/mmwr.mm7110a2
  
  In the report, “Characteristics and Adverse Events of Patients for Whom Nifurtimox Was Released Through CDC-Sponsored Investigational New Drug Program for Treatment of Chagas Disease — United States, 2001–2021,” on page 371, the 11th sentence in the first paragraph should have read, “On August 6, 2020, the Food and Drug Administration (FDA) announced approval of a nifurtimox product, Lampit(Bayer), for treatment of Chagas disease in patients aged <18 years weighing ≥5.5 lbs (≥2.5 kg).”
  
  
• Subjects:
  Published Erratum
• Source:
  MMWR Morbidity Mortal Weekly Rep. 71(12):474
• Series:
  Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
• DOI:
  http://dx.doi.org/10.15585/mmwr.mm7112a4
• ISSN:
  0149-2195 (print) ; 1545-861X (digital)
• Pubmed ID:
  35324882
• Pubmed Central ID:
  PMC8956336
• Document Type:
  Journal Article
• Genre:
  Published Erratum
• Pages in Document:
  1 pdf page
• Volume:
  71
• Issue:
  12
• Collection(s):
  Morbidity and Mortality Weekly Report (MMWR)
• Main Document Checksum:
  urn:sha-512:470d0fba626721e2e7f811ec22cba124f6115ec4e24799032861239b29a2749adef2d9afd87d95be3354370bec898beba37ee08d2d2a36c457b63ee93efc0b78
• Download URL:
  https://stacks.cdc.gov/view/cdc/115849/cdc_115849_DS1.pdf
• File Type:
  [PDF - 48.68 KB ]